IAS 2019
2-Drug DTG/3TC Regimen Gives More Choice to People With HIV
The two-drug regimen of dolutegravir and lamivudine appears safe and effective compared with three-drug regimens ...
SEPTEMBER 18, 2019
Investigational 2-Drug HIV Regimen Appears Safe, Effective
Merck's islatravir is an investigational first-in-class nucleoside reverse transcriptase translocation inhibitor ...
SEPTEMBER 13, 2019
New HIV Vaccine, Prevention Trials Show ‘Holy Grail’ Getting Closer
New HIV vaccine research and PrEP trials give hope to the ability to prevent HIV infection around the world.
JULY 26, 2019
Load more